Related Experiment Videos
Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography
D F Worsley1, A Celler, M J Adam
1Division of Nuclear Medicine, Vancouver Hospital and Health Sciences Centre, B.C., Canada.
AJR. American Journal of Roentgenology
|March 1, 1997
Summary
18F-fluorodeoxyglucose (FDG) SPECT imaging effectively differentiates malignant from benign pulmonary nodules, especially those larger than 2 cm. However, smaller malignant nodules were not adequately detected by this imaging method.
Area of Science:
- Nuclear Medicine
- Radiology
- Oncology
Background:
- Pulmonary nodules require accurate differentiation between benign and malignant types.
- Diagnostic imaging plays a crucial role in identifying malignant pulmonary lesions.
Purpose of the Study:
- To assess the effectiveness of single-photon emission computed tomography (SPECT) using 18F-fluorodeoxyglucose (FDG) in distinguishing malignant from benign pulmonary nodules.
- To evaluate the feasibility and efficacy of FDG SPECT for pulmonary nodule characterization.
Main Methods:
- Prospective evaluation of 26 patients with 28 indeterminate pulmonary lesions.
- Administration of FDG (5 MBq/kg) followed by dual-head SPECT imaging.
- Analysis of lesion size and FDG uptake for malignancy assessment.
Main Results:
- FDG SPECT demonstrated 81% sensitivity and 100% specificity for malignant nodules.
- All malignant nodules ≥ 2 cm (16/16) showed positive FDG uptake.
- Only 20% (1/5) of malignant nodules < 2 cm showed positive uptake.
Conclusions:
- FDG SPECT is useful for differentiating malignant from benign pulmonary nodules ≥ 2 cm.
- Current FDG SPECT technology has limitations in detecting smaller malignant pulmonary nodules due to lower sensitivity.